Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer [NA]
This clinical trial is investigating PET/CT imaging changes during chemoimmunotherapy and radiation therapy for stage IV non-small cell lung…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
This prospective multicenter study investigates whether traditional Chinese medicine syndrome patterns influence the efficacy of EGFR-TKI th…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Retifanlimab and Ruxolitinib In Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of retifanlimab and ruxolitinib in solid malignancies is currently recruiting, including non-small cell lung cancer and re…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Electro-Acupuncture in Lung cancER : EALER Study [NA]
Clinical trial update for the Electro-Acupuncture in Lung Cancer (EALER Study) investigating acupuncture in non-small cell lung cancer; the …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]
Seagen is conducting a Phase 1 study of SGN-MesoC2 in advanced solid tumors, including non-small cell lung cancer, ovarian cancer, pancreati…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery [Phase 2]
This clinical trial update describes a Phase 2 study evaluating whether adding fianlimab to cemiplimab and chemotherapy improves safety and …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib [Phase 2]
Phase 2 trial update comparing osimertinib plus chemotherapy versus osimertinib alone in EGFR-mutant non-small cell lung cancer with persist…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC [Phase 3]
This document describes an ongoing Phase 3 trial evaluating THIO plus cemiplimab versus chemotherapy as third-line treatment for advanced/me…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating TJ101 for safety, pharmacokinetics, and efficacy in advanced/metastatic solid tumors, including non-small …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 clinical trial update for ONO-7428 in participants with unresectable advanced or recurrent solid tumors, including non-small cell lu…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer [Phase 2]
Phase 2 clinical trial update on 125I seed implantation plus systemic therapy for oligoprogressive non-small cell lung cancer or colorectal …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Avutometinib (VS-6766) with Sotorasib, with or without Defactinib, in KRAS G12C NSCLC; currently active …
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors [Phase 1, Phase 2]
A first-in-human Phase 1/2 trial of JAB-8263 in adults with advanced tumors is currently recruiting across multiple cancer types including l…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Tislelizumab Combined With Thoracic Radiotherapy as Neoadjuvant Therapy for Resectable NSCLC [Phase 2]
A Phase 2 clinical trial investigating tislelizumab in combination with thoracic radiotherapy as neoadjuvant therapy for resectable non-smal…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer [Phase 2]
Phase II neoadjuvant trial evaluating Sacituzumab Tirumotecan in combination with Osimertinib or Sacituzumab Tirumotecan alone for resectabl…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC [Phase 2]
A Phase 2 trial evaluating QL1706 in combination with chemotherapy for advanced immune-mediated non-small cell lung cancer is currently recr…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating WAST Cell in combination with docetaxel for PD-1 inhibitor-resistant advanced non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors [Phase 2]
A Phase 2 clinical trial is investigating iruplinalkib tablets as postoperative adjuvant therapy for Stage IA ALK-positive non-small cell lu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery [NA]
A clinical trial is testing a mobile app-delivered dyadic yoga program for patients with non-small cell lung cancer undergoing thoracic radi…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
LOTUS-CC is an observational study at the University of Rochester aimed at uncovering subtypes of cancer cachexia in patients with advanced …
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy [Phase 2]
This clinical trial update describes a Phase II adjuvant therapy study in resectable non-small cell lung cancer using L-TIL plus tislelizuma…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
This clinical trial update describes a precision treatment strategy for non-small cell lung cancer using patient-derived tumor-like cell clu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer [NA]
A clinical trial evaluating circulating tumor DNA guided treatment monitoring in advanced non-small cell lung cancer is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
This clinical trial update reports on real-world outcomes and safety of atezolizumab in routine practice. It includes patients with urotheli…